Skip to content

Effect of eHealth Cardiac Rehabilitation Incorporating Mindfulness for Patients With Coronary Heart Disease

Effect of Mindfulness-based eHealth Cardiac Rehabilitation on Psychological Wellbeing and Risk Factor Management of Patients With Coronary Heart Disease: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07109752
Acronym
eCR
Enrollment
146
Registered
2025-08-07
Start date
2024-07-20
Completion date
2026-01-30
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease (CHD)

Keywords

cardiac rehabilitation, mindfulness, eHealth

Brief summary

People with coronary heart disease (CHD) often feel more stressed, which can increase the risk of having another heart problem. Cardiac rehabilitation (CR) is a common treatment for those with CHD, focusing on changing lifestyles and managing the disease. However, it often does not address stress management adequately. There is also a lack of psychological therapy and involvement of mental health professionals in online CR programs. Because traditional CR programs have low participation rates, online platforms are becoming more popular for providing rehabilitation support. This is important because more than half of people with CHD report high stress levels, which can cause or worsen heart problems. To address this issue, the proposed study will test an online CR program that includes mindfulness to help manage stress for CHD patients.

Detailed description

The proposed project is a study designed to test the effects of an online cardiac rehabilitation program, which includes mindfulness, on stress and health outcomes for people with coronary heart disease (CHD). The study will last 12 weeks and will be structured as a single-blinded, two-group randomized controlled trial. This means that participants will be randomly assigned to either the treatment group or a control group, and they won't know which group they're in. After the trial, there will be an evaluation to gather more in-depth insights. Participants will be asked to complete assessments using questionnaires and activity monitors at the start of the study, at 6 weeks, and at 12 weeks. Each assessment will take about 40 minutes, and there will also be a 30 to 40-minute interview. Those in the intervention group will have a face-to-face meeting to set goals and learn how to use the CR website and activity monitors, which will take about 50 minutes. They will be encouraged to use the website weekly to learn about healthy lifestyle changes, like walking briskly for 30 minutes a day, eating a healthy diet, listening to mindfulness audios, and not smoking. A nurse will call them every two weeks for the first six weeks to check in. The study is led by an Assistant Professor who has the necessary office space and access to various facilities to support the research. She specializes in cardiovascular health and has established connections in the field of cardiac rehabilitation, which are valuable for successfully conducting the study. The team includes co-investigators with expertise in physiotherapy, exercise rehabilitation, psychiatric nursing, and intensive care nursing, ensuring the study is well-supported and that results are properly reported and published.

Interventions

BEHAVIORALeHealth cardiac rehabilitation

A face-to-face interview for goal setting and action planning, as well as learning the use of CR website and accelerometer.

Sponsors

Tung Wah College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

People will be eligible for this study if they were: 1. diagnosed with CHD (within the past 6 months), 2. undergone conservative treatment, such as percutaneous coronary intervention (PCI) and/ or medication, 3. currently under stable medication regimen and discharged to home. 4. aged 18 years or older, 5. reported scores ranging from 3 (to some degree) to 5 (very much) scores on a single-item stress symptoms scale (Elo et al., 2003), 6. using a computer and/or smartphone to access the Internet at home, 7. and, read and speak Chinese.

Exclusion criteria

1. diagnosis of acute psychotic disease; 2. presence of a life-limiting condition; 3. prescribed contradictions to physical activity; and, 4. presence of hearing, visual, or ambulatory disorders

Design outcomes

Primary

MeasureTime frameDescription
Perceived stress levelbaseline, 6-week, 12- weekThe Perceived Stress Scale (PSS-10), with total scores ranging from 0 to 40 and higher scores indicating higher psychological stress

Secondary

MeasureTime frameDescription
Anxiety levelbaseline, 6-week, 12-weekGeneralized Anxiety Disorder 7-item, seven items ranges from 0 to 21 scores. 0-4: minimal anxiety. 5-9: mild anxiety. 10-14: moderate anxiety. 15-21: severe anxiety.
Depression levelbaseline, 6-week, 12-weekPatient Health Questionnaire (PHQ-9) with total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.
Physical activitybaseline, 6-week, 12-weekDaily steps measured by accelerometer
Sleepbaseline, 6-week, 12-weekSleep time measured by accelerometer
Health Related Quality of lifebaseline, 6-week, 12-weekShort-Form Six Dimensions (SF-6D), six items ranged from 6- 37 scores, with higher score indicate lower quality of life

Countries

Hong Kong

Contacts

Primary ContactJingjing Su, PhD
jjsu@twc.edu.hk852-37256115

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026